
GNCC Capital, Inc.
Share · US38013E2037 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GNCC Capital, Inc.
No Price
Closing Price OTC 28.04.2026:
0,00005 USD
28.04.2026 20:00
Current Prices from GNCC Capital, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
GNCP
|
USD
|
28.04.2026 20:00
|
0,00005 USD
| 0,00 USD |
Company Profile for GNCC Capital, Inc. Share
GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.
Company Data
Name GNCC Capital, Inc.
Company GNCC Capital, Inc.
Website
https://www.gncc-capital.com
Primary Exchange
UTC
ISIN US38013E2037
Asset Class Share
Sector Basic Materials
Industry Gold
CEO Nicolaas Edward Blom
Country United States of America
Currency USD
Employees -
Address 848 North Rainbow Boulevard, 89107 Las Vegas
IPO Date 2009-09-01
Stock Splits
| Date | Split |
|---|---|
| 11.12.2008 | 1:15 |
| 29.03.2007 | 1:100 |
| 08.11.2004 | 5:1 |
| 28.10.2004 | 5:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | GNCP |
More Shares
Investors who hold GNCC Capital, Inc. also have the following shares in their portfolio:

